News
NIH funds to nurture the women’s health research leaders of tomorrow

A new project to develop the women’s health research leaders of the future has received significant backing.
The Icahn School of Medicine at Mount Sinai has received a US$4.5m, five-year K12 award from the National Institutes of Health (NIH) to establish a pioneering programme that will train the next generation of leaders in women’s health research.
The programme, called the Mount Sinai Life-course Exposomics Analytic Program (LEAP) in Women’s Health, is led by Rosalind J. Wright, dean for public health and chair of the Department of Public Health at the Icahn School of Medicine.
LEAP is part of the NIH’s Building Interdisciplinary Research Careers in Women’s Health initiative. LEAP is currently the initiative’s only active and funded program in New York State and the first nationally to integrate exposomics in women’s health research training.
LEAP will focus on the emerging field of exposomics—the study of how health is affected by the totality of environmental exposures across a person’s life, from conception onward. The program will provide support for three junior faculty scholars each year, giving them advanced training, mentorship, and resources to build independent research careers in women’s health.
“Advancing personalised medicine requires a deeper understanding of women’s health across the lifespan,” Dr. Wright said.
“This includes conditions unique to women, such as reproductive outcomes, endometriosis, menopause, and gynecologic cancers, as well as disorders that affect women differently than men, including heart disease, lung disease, metabolic disorders, and mental health conditions. LEAP will allow us to accelerate training for early-career scientists and prepare them to lead innovative research that improves health outcomes for women everywhere.”
The programme will provide scholars with a strong foundation in life-course theory, exposure science, epidemiology, and data science—essential tools for studying how environmental, social, nutritional, and chemical exposures influence women’s health across the lifespan. LEAP scholars will work closely with experts across disciplines including environmental medicine, obstetrics and gynecology, pediatrics, geriatrics, psychiatry, oncology, genomics, artificial intelligence, biomedical engineering, public health, and others.
“This new initiative builds upon Mount Sinai’s long-standing commitment to women’s health and environmental health research,” said Eric J. Nestler, interim dean, Nash Family Professor of Neuroscience at the Icahn School of Medicine, and executive vice president and chief scientific officer of the Mount Sinai Health System
“Our institution has pioneered studies in how environmental exposures shape disease risk, and we are now uniquely positioned to integrate that expertise with women’s health research. LEAP will create a powerful training environment that not only prepares future leaders, but also generates discoveries with the potential to transform care for women across their lives.”
The Icahn School of Medicine at Mount Sinai is the sole academic partner for the seven member hospitals of the Mount Sinai Health System, one of the largest academic health systems in the US, providing care to New York City’s large and diverse patient population.
News
Perimenopause may offer “window of opportunity” for heart disease prevention
News
Research project of the year shortlist revealed

The Femtech World Awards is proud to reveal the shortlist for Research Project of the Year as part of the third annual global celebration of innovation, impact and leadership across women’s health.
From fertility science and perimenopause research to regional ecosystem analysis, the shortlisted projects reflect the breadth and growing influence of femtech research worldwide.
The category is sponsored by OncoGenomX, with the winner to be selected by a representative from the organisation.
OncoGenomX is dedicated to offering solutions and providing comprehensive support services that empower Drug Developers, Clinical Researchers, Oncologists,NextGenSeq Diagnostics Laboratories, NextGenSeq Service Organisations, Cancer Diagnostics and Therapeutics Companies to achieve their ambitious goals
The shortlisted entries for Research Project of the Year are:

Women’s health remains significantly underserved in South-East Asia, with persistent gaps in access, awareness, and quality of care carrying substantial social and economic costs.
This report examines the femtech landscape in Indonesia, the Philippines, Singapore, Thailand, and Vietnam, highlighting market trends, emerging technologies including artificial intelligence, and the evolving support ecosystem.
It identifies key challenges facing femtech founders, including limited access to finance, low awareness and persistent stigma, marketing constraints linked to content moderation, and gaps in tailored ecosystem support.

Led by Stephanie Willson, MD, of the IVI RMA Global Research Alliance, the study explored whether embryos that show certain chromosome abnormalities during genetic testing may still have the potential to result in a healthy pregnancy and live birth.
The research analysed more than 7,600 frozen embryo transfers and found that some embryos previously considered unlikely to succeed were still capable of leading to successful pregnancies, although at lower rates than embryos without abnormalities.
The findings could help fertility clinics and patients make more informed decisions during IVF treatment, particularly in cases where there are limited embryos available.
Rather than automatically discarding these embryos, the research supports a more evidence-based and personalised approach to fertility care.

For many women, perimenopause can feel confusing and unpredictable, with limited research explaining what is happening in their bodies.
Natural Cycles set out to change that by leading one of the largest studies ever conducted on menstrual and ovulatory patterns, uncovering new insights into how ovulation behaves as women approach menopause.
Conducted in collaboration with researchers from George Washington University, Seattle Clinical Research Center, Gennev and the University of California San Diego, the study analysed nearly one million menstrual cycles from more than 197,000 women aged 18–52 across more than 140 countries.
The scale of this dataset made it possible to explore menstrual patterns and ovulation in far greater detail than has traditionally been possible in women’s health research.
The Femtech World Awards celebrates the innovators, researchers and organisations driving meaningful progress in women’s health.
What happens next
Winners across all categories will be revealed during the virtual ceremony on June 19, with winners receiving a trophy and an interview with a Femtech World journalist.
Mental health
Women over 40 seeking raves for mental health benefits
Entrepreneur3 weeks agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
News2 weeks agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Fertility4 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Diagnosis3 weeks agoNew meta-analysis further supports low re-excisions and high placement accuracy with the Magseed marker
Menopause4 weeks agoMore research needed to understand link between brain fog and menopause, expert says
Mental health3 weeks agoLifting weights shows mental health and cognitive benefits in older women, study finds
Wellness3 weeks agoResistance training has preventative effects in menopause, study finds
Pregnancy3 weeks agoNIPT or NT scan? Why the 2026 evidence supports doing Both








